A5071517923- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Viral-associated cancers and disorders
- Nutrition and Health in Aging
- Childhood Cancer Survivors' Quality of Life
- CNS Lymphoma Diagnosis and Treatment
- Frailty in Older Adults
- Acute Lymphoblastic Leukemia research
- Body Composition Measurement Techniques
- Glioma Diagnosis and Treatment
- Patient-Provider Communication in Healthcare
- Myasthenia Gravis and Thymoma
- HIV/AIDS drug development and treatment
- Parkinson's Disease and Spinal Disorders
- Clinical Nutrition and Gastroenterology
- Immune Cell Function and Interaction
- Neutropenia and Cancer Infections
- Venous Thromboembolism Diagnosis and Management
- Galectins and Cancer Biology
- T-cell and Retrovirus Studies
- Peripheral Neuropathies and Disorders
- Cancer survivorship and care
- Palliative Care and End-of-Life Issues
- Lung Cancer Treatments and Mutations
- Vascular Malformations and Hemangiomas
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
2008-2024
Centro Medico Nacional Siglo XXI
2006
Mexican Social Security Institute
2006
Hospital de Especialidades
2006
Real-world evidence on non-Hodgkin lymphoma (NHL) management in Latin America is currently lacking. The objective of this study was to describe treatment characteristics and outcomes NHL America.A total 2,967 patients with aggressive indolent subtypes, including diffuse large B-cell (DLBCL), follicular (FL), mantle-cell (MCL), mucosa-associated lymphoid tissue (MALT) lymphoma, incident or prevalent diagnosis between 2006 2015, were retrospectively identified using clinical charts registered...
Abstract Therapeutic plasma exchange (TPE) is an effective treatment in Myasthenia gravis (MG) and Guillain‐Barré syndrome (GBS) 5% human albumin the replacement fluid of choice; however, it expensive. More recently, has been suggested that starch a safe cheaper choice to albumin. Objective: To evaluate our 5‐year experience using 3% hydroxyethyl (HES) mixture, as TPE for these diseases. Materials methods: Retrospective study carried out from January 2001 through September 2006. We included...
Previous studies have demonstrated that a low skeletal muscle mass (SMM) is an adverse factor for overall survival (OS) in diffuse large B-cell lymphoma (DLBCL). However, its association with the treatment response has not been extensively investigated. This study aimed to determine between and DLBCL patients. We conducted retrospective cohort of 123 patients DLBCL, whom SMM was assessed using computed tomography before chemotherapy administration. The demographic characteristics those...
Extranodal NK/T-cell lymphoma, nasal type (ENKTCL) has a high prevalence in Asia and Latin American countries, such as Mexico, where it encompasses 40% of all T-cell non-Hodgkin lymphomas. Historically, responses to anthracycline-based therapies have been disappointing. Since data about the effectiveness L-asparaginase-based regimens Mexico are limited, we compared both our center.We performed retrospective cohort patients with newly diagnosed ENKTCL, who were divided into two groups for...
CNS involvement in Hodgkin lymphoma is extremely rare, and usually presents with focal weakness, nonspecific sensitive symptoms, headache, altered mental status, seizures.Oy-sters c during advanced stages, most commonly within the first 2 years after initial diagnosis.c CSF findings are low positivity rates on flow cytometry, which makes essential need for tissue sampling.A 43-year-old woman hospitalized acute bacterial cholangitis treated piperacillin/ tazobactam meropenem developed day 10...